Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Tumor Progression02:07

Tumor Progression

6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

791
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
791

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

αKG-mediated carnitine synthesis drives DNA repair via histone acetylation.

Nature·2026
Same author

Cross-assay RNA modeling reveals cancer biomarkers.

bioRxiv : the preprint server for biology·2026
Same author

On the predictability of progression-free survival in ovarian cancer from NanoString gene expression data.

bioRxiv : the preprint server for biology·2026
Same author

Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular composition.

bioRxiv : the preprint server for biology·2026
Same author

Predicting missing links in food webs using stacked models and species traits.

Nature communications·2026
Same author

Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor.

Molecular cancer therapeutics·2026
Same journal

Spatiotemporal control of myoblast identity drives muscle diversity in the <i>Drosophila</i> leg.

Science advances·2026
Same journal

Stellar feedback drives the baryon deficiency in low-mass galaxies.

Science advances·2026
Same journal

Antiferroelectric thin films embedded with ferroelectric switching loop for giant negative electrocaloric effect.

Science advances·2026
Same journal

Tetraphosphorylated phthalocyanine-based self-assembled monolayer stabilizes perovskite photovoltaics.

Science advances·2026
Same journal

Dual-mode analysis of ischemic stroke based on urine SERS spectra and carotid B-ultrasound.

Science advances·2026
Same journal

Remote homology and functional genetics unmask deeply preserved Scm3/HJURP orthologs in metazoans.

Science advances·2026
See all related articles

Related Experiment Video

Updated: Nov 3, 2025

A Label-Free Segmentation Approach for Intravital Imaging of Mammary Tumor Microenvironment
10:39

A Label-Free Segmentation Approach for Intravital Imaging of Mammary Tumor Microenvironment

Published on: May 24, 2022

2.5K

Decoding the dynamic tumor microenvironment.

Aaron Clauset1,2,3, Kian Behbakht4,5,6, Benjamin G Bitler7,6

  • 1Department of Computer Science, University of Colorado Boulder, Boulder, CO 80309, USA.

Science Advances
|June 5, 2021
PubMed
Summary
This summary is machine-generated.

Machine learning offers a promising avenue to enhance cancer patient outcomes. This technology can improve diagnostic accuracy and treatment efficacy for various cancers.

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.4K
A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

10.6K

Related Experiment Videos

Last Updated: Nov 3, 2025

A Label-Free Segmentation Approach for Intravital Imaging of Mammary Tumor Microenvironment
10:39

A Label-Free Segmentation Approach for Intravital Imaging of Mammary Tumor Microenvironment

Published on: May 24, 2022

2.5K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.4K
A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

10.6K

Area of Science:

  • Oncology
  • Artificial Intelligence
  • Biomedical Informatics

Background:

  • Cancer remains a leading cause of mortality worldwide.
  • Traditional diagnostic and treatment methods face limitations in precision and effectiveness.
  • Advancements in computational power and data availability enable novel approaches.

Purpose of the Study:

  • To explore the potential of machine learning (ML) in improving cancer outcomes.
  • To identify key areas within oncology where ML can be most impactful.
  • To highlight the opportunities for integrating ML into clinical cancer care.

Main Methods:

  • Review of current literature on ML applications in cancer research.
  • Analysis of ML algorithms used for cancer diagnosis, prognosis, and treatment.
  • Case studies illustrating successful ML implementation in oncology.

Main Results:

  • ML demonstrates significant potential in early cancer detection and risk prediction.
  • Personalized treatment strategies can be optimized using ML-driven predictive models.
  • ML aids in identifying novel therapeutic targets and predicting treatment response.

Conclusions:

  • Machine learning presents a transformative opportunity to enhance cancer outcomes.
  • Integration of ML into clinical practice can lead to more accurate diagnoses and effective treatments.
  • Further research and validation are crucial for widespread adoption of ML in oncology.